4//SEC Filing
DEC TIMOTHY C 4
Accession 0001628280-25-007526
CIK 0001356576other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:16 PM ET
Size
14.1 KB
Accession
0001628280-25-007526
Insider Transaction Report
Form 4
DEC TIMOTHY C
Senior Vice-President & CFO
Transactions
- Award
Common Stock
2025-02-22+500→ 8,591 total - Award
Common Stock
2025-02-23+2,500→ 14,091 total - Disposition to Issuer
Restricted Stock Unit
2025-02-22−3,000→ 9,000 total→ Common Stock (3,000 underlying) - Award
Common Stock
2025-02-22+3,000→ 11,591 total - Disposition to Issuer
Restricted Stock Unit
2025-02-23−2,500→ 5,000 total→ Common Stock (2,500 underlying) - Disposition to Issuer
Restricted Stock Unit
2025-02-22−500→ 500 total→ Common Stock (500 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F2]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
- [F3]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025.
- [F4]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001194020
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:16 PM ET
- Size
- 14.1 KB